Pathologic grades of bronchial biopsy samples at baseline and after 6 months of intervention: person-specific analysis
| . | Complete response . | Partial response . | Stable disease . | Progressive disease . | Total . |
|---|---|---|---|---|---|
| Placebo | 15 (28%) | 7 (13%) | 4 (8%) | 27 (51%) | 53 (100%)* |
| Pulmicort Turbuhaler | 16 (30%) | 5 (9%) | 8 (15%) | 23 (43%) | 53 (100%) |
| P † | 0.83 | N/A | N/A | 0.56 |
| . | Complete response . | Partial response . | Stable disease . | Progressive disease . | Total . |
|---|---|---|---|---|---|
| Placebo | 15 (28%) | 7 (13%) | 4 (8%) | 27 (51%) | 53 (100%)* |
| Pulmicort Turbuhaler | 16 (30%) | 5 (9%) | 8 (15%) | 23 (43%) | 53 (100%) |
| P † | 0.83 | N/A | N/A | 0.56 |
NOTE. The proportion of subjects in the response categories of each treatment group is shown by the number and percentage.
One participant in the Pulmicort group was omitted from this analysis because not all of the baseline dysplasia sites could be graded at 6 months due to incomplete epithelium.
P is from a two-sample test for equality of proportions with continuity correction.
Abbreviation: N/A, not applicable.